Anna Brown

Adjunct Associate Professor

University of South Australia

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Science Medical Science professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anna Brown is an Adjunct Associate Professor at the University of South Australia. Her research primarily focuses on myelodysplastic syndromes and myeloid neoplasms, with recent articles addressing topics such as risk stratification for TP53 mutations and the impact of hereditary platelet disorders. Anna is dedicated to integrating genetic assessments into clinical practice to improve patient outcomes in hematological malignancies.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Andreas Schreiber

Affiliate Senior Lecturer

University of Adelaide

AUSTRALIA

View details

Claire Homan

University of South Australia

AUSTRALIA

View details

Mihir D Wechalekar

Flinders University

AUSTRALIA

View details

Kelly Lim

University of Adelaide

AUSTRALIA

View details

Christopher Hahn

University of South Australia

AUSTRALIA

View details

Hamish Scott

University of South Australia

AUSTRALIA

View details

Matthew Kutny

Assistant Professor

The University of Alabama

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Brown

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26

Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges

And the germline beat (AML) goes on

B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations.

To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML

A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability

Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)

Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss.

Collaborators (7)

Andreas Schreiber

Claire Homan

Mihir D Wechalekar

Kelly Lim

Christopher Hahn

Hamish Scott

Matthew Kutny

Make your next move.